
This episode discusses the latest advancements and strategies in the management of advanced ovarian cancer, featuring insights from leading experts in the field.
Featuring perspectives from Dr Ramez N Eskander, Dr Ursula Matulonis, Dr Kathleen N Moore, Dr Alexander B Olawaiye and Dr David M O'Malley, moderated by Dr Moore, including the following topics: Introduction (00:00) Current Role of PARP Inhibitors in the Management of Advanced Ovarian Cancer (OC) — Prof Eskander (2:40) Strategies Targeting Folate Receptor Alpha in Advanced OC — Dr Matulonis (27:41) Other Approved and Promising Investigational Antibody-Drug Conjugates for Advanced OC — Dr Moore (52:12) Other Novel Agents and Strategies for Advanced OC — Dr O'Malley (1:14:35) Diagnosis and Management of Adverse Events Associated with Common Therapies for Advanced OC — Dr Olawaiye (1:39:39) CME information and select publications
Host: Dr Kathleen N Moore
Guests: Dr Ramez N Eskander, Dr Ursula Matulonis, Dr Alexander B Olawaiye, Dr David M O'Malley
Explore listener stats, chart rankings, contacts and more on the Gynecologic Oncology Update podcast page.